NCT00681330
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +7 more
- Locations
-
- The Institutute of Medical Science, University of Tokyo 4-6-1, Shirokanedai, Minato-ku, Tokyo, Japan
Clinical trial condition
Digestive System Neoplasms
Explore clinical trials studying Digestive System Neoplasms. Study availability and eligibility vary by location and protocol.
14,252 public trials
3,233 recruiting studies
Digestive System Neoplasms trial results
Completed
STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced Diarrhea
NCT00050635
- Conditions
- Colonic Diseases, Colorectal Neoplasms, Diarrhea, +12 more
- Locations
-
- Kenmar Research Institute Burbank, California, United States
- Bay Area Cancer Research Group Concord, California, United States
- Compassionate Cancer Care medical Group, Inc. Fountain Valley, California, United States
- California Cancer Care, Inc. Greenbrae, California, United States
NCT00922181
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Liver Diseases, +3 more
- Locations
-
- University Hospital Gasthuisberg Leuven, Vlaams-Brabant, Belgium
NCT00344552
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +7 more
- Locations
-
- Local Institution Nagoya, Aichi-ken, Japan
- Local Institution Kashiwa-Shi, Chiba, Japan
- Local Institution Sagamihara-Shi, Kanagawa, Japan
- Local Institution Osaka, Japan
NCT00457743
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +6 more
- Locations
-
- Pfizer Investigational Site Kashiwa, Chiba, Japan
- Pfizer Investigational Site Sapporo, Hokkaido, Japan
- Pfizer Investigational Site Suita, Osaka, Japan
- Pfizer Investigational Site Chuo-ku, Tokyo, Japan
NCT00125021
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +10 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Completed
Docetaxel in Combination With Iressa in Previously Treated Patients With Pancreatic Cancer
NCT00137761
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
NCT00165568
- Conditions
- Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +13 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
NCT01002443
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +6 more
- Locations
-
- Research Institute and Hospital, National Cancer Center Goyang-si, Gyeonggi-do, South Korea
NCT00467922
- Conditions
- Colitis, Colitis, Ulcerative, Colon Cancer, +28 more
- Locations
-
- Spectrum Health Grand Rapids, Michigan, United States